BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 16919785)

  • 1. MAPK-specific tyrosine phosphatases: new targets for drug discovery?
    Barr AJ; Knapp S
    Trends Pharmacol Sci; 2006 Oct; 27(10):525-30. PubMed ID: 16919785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
    Burke TR; Zhang ZY
    Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
    Bialy L; Waldmann H
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic approaches to studying protein tyrosine phosphatases.
    Liang F; Kumar S; Zhang ZY
    Mol Biosyst; 2007 May; 3(5):308-16. PubMed ID: 17460790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
    Evdokimov AG; Pokross M; Walter R; Mekel M; Cox B; Li C; Bechard R; Genbauffe F; Andrews R; Diven C; Howard B; Rastogi V; Gray J; Maier M; Peters KG
    Acta Crystallogr D Biol Crystallogr; 2006 Dec; 62(Pt 12):1435-45. PubMed ID: 17139078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases.
    Eswaran J; von Kries JP; Marsden B; Longman E; Debreczeni JE; Ugochukwu E; Turnbull A; Lee WH; Knapp S; Barr AJ
    Biochem J; 2006 May; 395(3):483-91. PubMed ID: 16441242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural compounds as a source of protein tyrosine phosphatase inhibitors: application to the rational design of small-molecule derivatives.
    Ferreira CV; Justo GZ; Souza AC; Queiroz KC; Zambuzzi WF; Aoyama H; Peppelenbosch MP
    Biochimie; 2006 Dec; 88(12):1859-73. PubMed ID: 17010496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and mechanistic approaches to the study of protein tyrosine phosphatases.
    Zhang ZY
    Acc Chem Res; 2003 Jun; 36(6):385-92. PubMed ID: 12809524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of protein tyrosine phosphatases and dual-specificity phosphatases in mammalian spermatozoa and their role in sperm motility and protein tyrosine phosphorylation.
    González-Fernández L; Ortega-Ferrusola C; Macias-Garcia B; Salido GM; Peña FJ; Tapia JA
    Biol Reprod; 2009 Jun; 80(6):1239-52. PubMed ID: 19211810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A one-step method to identify MAP kinase residues involved in inactivation by tyrosine- and dual-specificity protein phosphatases.
    Tárrega C; Pulido R
    Anal Biochem; 2009 Nov; 394(1):81-6. PubMed ID: 19583964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast substrate-trapping system for isolating substrates of protein tyrosine phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor type z.
    Fukada M; Kawachi H; Fujikawa A; Noda M
    Methods; 2005 Jan; 35(1):54-63. PubMed ID: 15588986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor and nonreceptor protein tyrosine phosphatases in the nervous system.
    Paul S; Lombroso PJ
    Cell Mol Life Sci; 2003 Nov; 60(11):2465-82. PubMed ID: 14625689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatases and breast cancer.
    Freiss G; Vignon F
    Crit Rev Oncol Hematol; 2004 Oct; 52(1):9-17. PubMed ID: 15363463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.
    Zhang ZY
    Annu Rev Pharmacol Toxicol; 2002; 42():209-34. PubMed ID: 11807171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for developing protein tyrosine phosphatase inhibitors.
    Tautz L; Mustelin T
    Methods; 2007 Jul; 42(3):250-60. PubMed ID: 17532512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTP1B and TC-PTP: regulators of transformation and tumorigenesis.
    Stuible M; Doody KM; Tremblay ML
    Cancer Metastasis Rev; 2008 Jun; 27(2):215-30. PubMed ID: 18236007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray crystallography and NMR as tools for the study of protein tyrosine phosphatases.
    Gulerez IE; Gehring K
    Methods; 2014 Jan; 65(2):175-83. PubMed ID: 23899694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.
    Barr AJ
    Future Med Chem; 2010 Oct; 2(10):1563-76. PubMed ID: 21426149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.